Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion type Assertion NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_head.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion description "[Chronic treatment with AVE3085 did not alter arterial BP or severe hyperglycaemia, but did lead to significantly increased production of eNOS (+95%), cGMP (+128%) and VASP phosphorylation (+65%) as well as to improved vascular function (+36%) associated with reduced production of ICAM-1 (-36%) and VCAM-1 (-58%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_provenance.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion evidence source_evidence_literature NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_provenance.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion SIO_000772 18825362 NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_provenance.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion wasDerivedFrom befree-20140225 NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_provenance.
- NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_assertion wasGeneratedBy ECO_0000203 NP755147.RA_5Erric_itXwrqMf1NEJdK4khB9hNqLesfGlGxKXDvI130_provenance.